Justin Zelin
Stock Analyst at BTIG
(3.39)
# 2,384
Out of 4,988 analysts
344
Total ratings
36.9%
Success rate
3.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Justin Zelin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IBRX ImmunityBio | Reiterated: Buy | $9 | $8.48 | +6.13% | 6 | Feb 2, 2026 | |
| JANX Janux Therapeutics | Reiterated: Buy | $100 | $16.59 | +502.77% | 8 | Jan 22, 2026 | |
| NBP NovaBridge Biosciences | Reiterated: Buy | $9 | $1.60 | +462.50% | 5 | Jan 6, 2026 | |
| AVBP ArriVent BioPharma | Reiterated: Buy | $45 | $28.90 | +55.71% | 2 | Jan 2, 2026 | |
| SNDX Syndax Pharmaceuticals | Reiterated: Buy | $56 | $17.62 | +217.82% | 26 | Jan 2, 2026 | |
| KURA Kura Oncology | Reiterated: Hold | n/a | $11.73 | - | 20 | Dec 9, 2025 | |
| TCRX TScan Therapeutics | Reiterated: Hold | n/a | $0.3119 | - | 10 | Dec 9, 2025 | |
| AAPG Ascentage Pharma Group International | Reiterated: Buy | $50 | $15.06 | +232.01% | 2 | Dec 2, 2025 | |
| JSPR Jasper Therapeutics | Reiterated: Buy | $7 | $0.6178 | +1,033.05% | 14 | Dec 2, 2025 | |
| IDYA IDEAYA Biosciences | Reiterated: Buy | $62 | $38.41 | +61.42% | 13 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $7.44 | +168.82% | 20 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $28.99 | +331.18% | 36 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.89 | n/a | 2 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $49.45 | n/a | 3 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $91 | $17.61 | n/a | 38 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $91 | $32.00 | n/a | 13 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0007 | n/a | 5 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $9.18 | n/a | 21 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.91 | n/a | 10 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $6.67 | n/a | 15 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.5397 | n/a | 22 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.36 | n/a | 19 | Jul 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.1288 | n/a | 8 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.13 | n/a | 14 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $0.37 | n/a | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 → $3 | $5.57 | n/a | 4 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.30 | n/a | 2 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $336.67 | n/a | 2 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $0.001 | n/a | 3 | Nov 11, 2020 |
ImmunityBio
Feb 2, 2026
Reiterated: Buy
Price Target: $9
Current: $8.48
Upside: +6.13%
Janux Therapeutics
Jan 22, 2026
Reiterated: Buy
Price Target: $100
Current: $16.59
Upside: +502.77%
NovaBridge Biosciences
Jan 6, 2026
Reiterated: Buy
Price Target: $9
Current: $1.60
Upside: +462.50%
ArriVent BioPharma
Jan 2, 2026
Reiterated: Buy
Price Target: $45
Current: $28.90
Upside: +55.71%
Syndax Pharmaceuticals
Jan 2, 2026
Reiterated: Buy
Price Target: $56
Current: $17.62
Upside: +217.82%
Kura Oncology
Dec 9, 2025
Reiterated: Hold
Price Target: n/a
Current: $11.73
Upside: -
TScan Therapeutics
Dec 9, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.3119
Upside: -
Ascentage Pharma Group International
Dec 2, 2025
Reiterated: Buy
Price Target: $50
Current: $15.06
Upside: +232.01%
Jasper Therapeutics
Dec 2, 2025
Reiterated: Buy
Price Target: $7
Current: $0.6178
Upside: +1,033.05%
IDEAYA Biosciences
Nov 4, 2025
Reiterated: Buy
Price Target: $62
Current: $38.41
Upside: +61.42%
Nov 4, 2025
Reiterated: Buy
Price Target: $20
Current: $7.44
Upside: +168.82%
Oct 30, 2025
Reiterated: Buy
Price Target: $125
Current: $28.99
Upside: +331.18%
Sep 17, 2025
Reiterated: Buy
Price Target: $8
Current: $1.89
Upside: n/a
Aug 14, 2025
Reiterated: Buy
Price Target: $45
Current: $49.45
Upside: n/a
Aug 11, 2025
Reiterated: Buy
Price Target: $91
Current: $17.61
Upside: n/a
Mar 11, 2025
Reiterated: Buy
Price Target: $91
Current: $32.00
Upside: n/a
Jan 14, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.0007
Upside: n/a
Sep 10, 2024
Reiterated: Buy
Price Target: $6
Current: $9.18
Upside: n/a
Sep 3, 2024
Reiterated: Buy
Price Target: $5
Current: $1.91
Upside: n/a
May 13, 2024
Reiterated: Buy
Price Target: $30
Current: $6.67
Upside: n/a
Mar 12, 2024
Reiterated: Buy
Price Target: $8
Current: $0.5397
Upside: n/a
Jul 6, 2023
Rated: Hold
Price Target: n/a
Current: $2.36
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $0.1288
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $1.13
Upside: n/a
Dec 4, 2020
Initiated Coverage: Buy
Price Target: $4
Current: $0.37
Upside: n/a
Nov 11, 2020
Reiterated: Buy
Price Target: $2 → $3
Current: $5.57
Upside: n/a
Nov 11, 2020
Reiterated: Buy
Price Target: $4
Current: $1.30
Upside: n/a
Nov 11, 2020
Reiterated: Buy
Price Target: $100
Current: $336.67
Upside: n/a
Nov 11, 2020
Reiterated: Buy
Price Target: $28
Current: $0.001
Upside: n/a